Table 2: Annualized age-specific incidence (per 100 000 population) of invasive pneumococcal disease among adults 65 years of age and older in Ontario, 2007-2014

Vaccine type	Rate (per 100 000 population) by age group
Vaccine type	65-74 yr	p value	75-84 yr	p value	≥ 85 yr	p value
All types	18.7	Reference	26.5	< 0.001	50.3	< 0.001
PCV7	1.3	Reference	1.6	0.205	4.0	< 0.001
Additional PCV13	5.3	Reference	6.8	0.001	12.4	< 0.001
PCV13	6.7	Reference	8.5	0.001	16.5	< 0.001
Unique PPV23	3.7	Reference	4.9	0.001	9.0	< 0.001
NVP	3.4	Reference	5.7	< 0.001	10.6	< 0.001

Note: NVP = non-vaccine preventable serotypes, PCV7 = 7-valent pneumococcal conjugate vaccine, PCV13 = 13-valent pneumococcal conjugate vaccine, PPV23 = 23-valent polysaccharide pneumococcal vaccine.